MarketCap
Facebook
X
TelegramQuarterly report 2024-Q1
added 05-14-2024
Motus GI Holdings Current Ratio 2011-2026 | MOTS
Annual Current Ratio Motus GI Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.59 | 1.2 | 1.59 | 2.08 | 2.66 | 9.21 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.21 | 1.2 | 3.06 |
Quarterly Current Ratio Motus GI Holdings
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.77 | 1.59 | 0.77 | 0.92 | 0.92 | 1.2 | 1.05 | 1.25 | 1.54 | 1.59 | 2.04 | 2.4 | 2.56 | 1.88 | 1.88 | 1.88 | 1.88 | 2.32 | 2.32 | 2.32 | 2.32 | 5.17 | 5.17 | 5.17 | 5.17 | 2.52 | 2.52 | 2.52 | 2.52 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.17 | 0.77 | 2.32 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
2.01 | $ 115.6 | 0.06 % | $ 35.1 B |  USA |
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
6.01 | $ 1.65 | -1.2 % | $ 2.19 M | USA |
 |
Aspira Women's Health
AWH
|
0.44 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
7.05 | $ 24.8 | 1.39 % | $ 689 M | USA |
 |
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
3.75 | $ 21.22 | -0.05 % | $ 1.13 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M |  Britain |
 |
Illumina
ILMN
|
6.69 | $ 127.82 | -0.05 % | $ 20.3 B | USA |
 |
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
1.69 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
13.4 | $ 15.81 | -3.07 % | $ 478 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | China |
 |
Lantheus Holdings
LNTH
|
1.96 | $ 84.53 | 0.24 % | $ 5.7 B | USA |
 |
Charles River Laboratories International
CRL
|
1.82 | $ 170.09 | 0.19 % | $ 8.43 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
1.3 | $ 417.28 | 1.64 % | $ 12 B | USA |
 |
Guardant Health
GH
|
0.953 | $ 89.33 | 0.47 % | $ 11.2 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.69 | $ 27.52 | 0.16 % | $ 20 B |  Niderland |
 |
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
2.95 | $ 1.93 | -2.08 % | $ 8.54 M | USA |
 |
Senseonics Holdings
SENS
|
1.94 | $ 7.17 | 1.7 % | $ 299 M | USA |
 |
Soleno Therapeutics
SLNO
|
4.96 | $ 52.75 | 0.05 % | $ 2.68 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B | Niderland |
 |
Neogen Corporation
NEOG
|
2.51 | $ 9.51 | -0.37 % | $ 2.06 B | USA |
 |
Biomerica
BMRA
|
3.23 | $ 2.15 | 0.7 % | $ 4.94 M | USA |
 |
Thermo Fisher Scientific
TMO
|
1.92 | $ 467.93 | -0.35 % | $ 176 B | USA |
 |
National Research Corporation
NRC
|
1.12 | $ 17.07 | -0.93 % | $ 382 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.29 | $ 101.57 | -0.59 % | $ 8.38 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 263.9 | 0.06 % | $ 22 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.746 | $ 0.65 | 0.95 % | $ 61.9 M | Irlanda |
 |
Celcuity
CELC
|
1.27 | $ 123.04 | 1.66 % | $ 5.75 B | USA |
 |
Twist Bioscience Corporation
TWST
|
3.8 | $ 60.76 | -0.3 % | $ 3.63 B | USA |
 |
OpGen
OPGN
|
3.97 | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
2.6 | $ 8.57 | 3.44 % | $ 1.1 B | USA |
 |
Myriad Genetics
MYGN
|
2.09 | $ 4.76 | -0.42 % | $ 441 M | USA |
 |
Natera
NTRA
|
2.02 | $ 204.88 | 0.55 % | $ 20.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.25 | $ 196.9 | 0.35 % | $ 21.9 B | USA |
 |
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
2.47 | - | -0.91 % | $ 14.7 B | USA |